Demand for Novel Delivery Systems Rising: Parenteral Systems Will Give Specialized Oral Delivery Methods a Run for Their Money

摘要

The demand for drug delivery systems in the U.S. will increase by over 10% annually to 132 billion dollar in 2012. Growth opportunities will extend to a wide range of compounds and formulations. Oral controlled-release medication will continue to account for the largest share of demand through 2012 due to favorable cost advantages, a wealth of potential new product applications, and significant efficacy benefits over conventional dosage formulations.